TURQUOISE-II: Trends in Liver Fibrosis Testing, Hepatic Synthetic Function, and Platelet Counts at Baseline and 12 Weeks After Treatment With ABT-450/r/Ombitasvir and Dasabuvir With Ribavirin in HCV Genotype 1-Infected Patients With Cirrhosis

Press/Media: Press / Media

PeriodDec 23 2014

Media coverage

1

Media coverage

  • TitleTURQUOISE-II: Trends in Liver Fibrosis Testing, Hepatic Synthetic Function, and Platelet Counts at Baseline and 12 Weeks After Treatment With ABT-450/r/Ombitasvir and Dasabuvir With Ribavirin in HCV Genotype 1-Infected Patients With Cirrhosis
    Media name/outletNational AIDS Treatment Advocacy Project
    CountryUnited States
    Date12/23/14
    PersonsFred Poordad